Overview
Shinichi Kameyama practices in Yokohama, Japan. Mr. Kameyama is rated as an Experienced expert by MediFind in the treatment of L1 Syndrome. His top areas of expertise are Neuronal Intranuclear Inclusion Disease (NIID), Myoclonic Epilepsy, L1 Syndrome, and Corpus Callosum Agenesis.
His clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of L1 Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Absence SeizureMr. Kameyama isExperienced. Learn about Absence Seizure.
- Corpus Callosum AgenesisMr. Kameyama isExperienced. Learn about Corpus Callosum Agenesis.
- Generalized Tonic-Clonic SeizureMr. Kameyama isExperienced. Learn about Generalized Tonic-Clonic Seizure.
- L1 SyndromeMr. Kameyama isExperienced. Learn about L1 Syndrome.
- Myoclonic EpilepsyMr. Kameyama isExperienced. Learn about Myoclonic Epilepsy.
- Neuronal Intranuclear Inclusion Disease (NIID)